Dr. Eaves holds a BA in Biology & Chemistry and a MSc in Genetics from Queen’s University, Kingston, Ontario, and a PhD in Immunology from the University of Manchester, UK. Following post-doctoral training in experimental hematology at the Ontario Cancer Institute under Dr. James Till in collaboration with Dr. Ernest McCulloch, she joined the faculty of the BC Cancer Agency and the University of British Columbia in 1973. In 1981, she and her husband co-founded the Terry Fox Laboratory at the BC Cancer Agency. Over the last 4 decades, Dr. Eaves’ has developed an internationally recognized research program that continues to address fundamental questions in normal and cancer stem cell biology. Her contributions have included the development and use of quantitative methods to molecularly and biologically characterize rare, functionally defined cells of the blood-forming system, the mammary gland, leukemia, and breast cancer that have become gold standards in these disciplines. More recently, her group has pioneered the creation of several models of de novo leukemia and breast cancer starting from primary sources of human cells. She has published more than 500 papers and has a long track record as a scientific leader and devoted mentor of >100 postgraduate trainees at all levels in multiple disciplines. She has also been an energetic lifelong contributor to the development of science policy and management in Canada and abroad, and maintains an active role in editing and reviewing scientific publications. She has received many prestigious national and international awards for her numerous and diverse accomplishments, including election as a Fellow of the Royal Societies of Canada and Edinburgh, the Noble Prize for Cancer Research, the Metcalf Lecture and Prize from the International Society of Hematology, and the Stratton Lifetime Achievement Award and Donnall Thomas Lecture and Award from the American Society of Hematology.
« Go Back